Abstract
General Reviews
Endogenous Cushing's syndrome (CS) is the Specific are the central obesity, muscle atrophy and asthenia, hypertension, glucose i n t o l e r a n c e , h y p e r l i p i d e m i a , a n d hypercoagulability. These complications are only partially reversible after the treatment of the subjacent disease, despite the cure of the hypercortisolism and the regression of clinical manifestations. Comorbidities and complications of the active phase of the disease are persistent for a long term after surgical or medical treatment of CS . (1, 2, 3, 4) Mortality in CS is increased: untreated patients have a 5-year survival rate estimated at 50% ; some studies to the insulin resistance in these patients was studied . Glucose intolerance and ( 9 , 1 0 ) diabetes are frequent in Cushing's syndrome and in many studies they reach 69% of cases (Table 2) .
Hypertension in Cushing's syndrome
In the active period, CS is associated with moderate hypertension, with extended General Reviews evolution, which is persistent after the adequate treatment of the disease. Cushing's syndrome is multifactorial (Table 3) . (11) The mechanisms of glucocorticoid-induced hypertension are partially elucidated, but studies showed the relationship with the i m b a l a n c e b e t w e e n v a s o d i l a t o r a n d vasoconstrictor factors (nitric oxide, prostacyclin, and endothelin 1), activation of mineralocorticoid receptors, and endothelial dysfunction . In the pathogenesis of (17, 18, 19, 20) hypertension in Cushing's syndrome i n t e r d e p e n d e n t p a t h o p h y s i o l o g i c a l pathways take part : (12, 13, 14, 15, 16) 1. increase of plasma volume, to which the following contribute: Some specialized centres recommend after a d r e n a l e c t o m y t h e e x t e n s i o n o f a n t i c o a g u l a n t t r e a t m e n t i n t (Table 4 ).
The indirect actions of glucocorticoids on the vascular wall cause significant changes at this level (Table 5 ).
All these mechanisms have the final result of vascular remodelling, which affects both large vessels and arterioles.
Subclinical hypercortisolism
Subclinical hypercortisolism represents the biochemical excess of cortisol, without classic signs and symptoms of manifested hypercortisolism. Classically it is accepted that subclinical Cushing's syndrome is r e f e r r i n g t o t h e a l t e r a t i o n o f t h e hypothalamic-pituitary-adrenal axis in patients with adrenal masses discovered incidentally, and who do not present signs and symptoms specific for manifested Cushing's syndrome. This simple definition became inadequate in the present time, and additionally certain imaging, clinical and hormone particularities were outlined, which allow the diagnosis of these patients . The (32, 33) term "adrenal incidentaloma" refers to a group of adrenal masses discovered accidentally during an imaging investigation.
The majority of these tumors are benign and and of cardiovascular mortality . (36, 37) In the present time the optimal strategy for the diagnosis and management of subclinical Therefore the chronic long-term monitoring of the co-morbidities is required.
